Bimekizumab Provides Rapid and Sustained Improvements in Scalp and Nail Outcomes in Patients With Moderate to Severe Plaque Psoriasis: 60 Week Results from a Randomized, Double Blinded, Phase 2b Extension Study. J of Skin 2019, 3, S34. https://doi.org/10.25251/skin.3.supp.34.